1 of 1
Story summary
- CBD and cannabigerol (CBG), two non-psychoactive cannabis compounds, may help treat MASLD.
- The study in The British Journal of Pharmacology shows these compounds improve liver health by enhancing energy management and waste clearance.
- Prof. Yossi Tam led the research and noted CBG reduced body fat and cholesterol levels.
- MASLD affects about one in three adults globally, and the team plans clinical trials for a cannabinoid-based treatment.
